Skip to main content
OpenTrials
Completed

NCT Number: NCT00929721

A Global Active Surveillance for Community Acquired Pneumonia

This study is an observational surveillance study to identify adults 50 years and older who present to a study healthcare facility with signs and symptoms of Community-Acquired Pneumonia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Community Acquired Pneumonia Community-Acquired Infections Community-Acquired Pneumonia Infections Pneumonia Respiratory Tract Diseases Respiratory Tract Infections

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pfizer Investigational Site

Chrzanów, 32-500, Poland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult subjects 50 years of age or older
  • Subject must reside in the surveillance area
  • Subjects who present to a study healthcare facility where the treating physician clinically suspects CAP

Exclusion criteria

  • Any subject who is transferred to a study healthcare facility after already being hospitalized for 48 hours or more at any other in-patient facility (such as a community hospital).
  • Hospital Acquired pneumonia (ie, develops signs and symptoms of pneumonia after being hospitalized for 48 hours or more).

Treatment and study plan

Blood draw

Procedure

culture for Streptococcus pneumoniae Frequency-1

Other names: Blood stick

Chest X-ray

Procedure

image of the lungs to assess changes consistent with pneumonia Frequency-1

Other names: Picture of lungs

urine specimen

Procedure

assay for the presence of Streptococcus pneumoniae Binax and UAD

Other names: urine dipstick test

Nasopharyngeal swab

Procedure

culture for Streptococcus pneumoniae Frequency-1

Other names: swab from inside the nose and throat

sputum

Procedure

culture for Streptococcus pneumoniae Frequency-1

Other names: collection secretions produced during cough

Primary outcomes

  1. Incidence rates of CAP in adults 50 years and older

    Time frame: up to 120 days from enrollment

Secondary outcomes

  1. Frequency of bacterial agents associated with CAP, Case fatality and incidence rates of CAP number and characteristics of subjects from outpatient clinics, emergency rooms, and hospital in-patient departments

    Time frame: up to 120 days from enrollment

Sponsors and collaborators

Lead sponsor

Pfizer

Industry

Registry information

Official study title

Global Active Surveillance for Community-Acquired Pneumonia (CAP) in Adults 50 Years and Older

Important dates

Study start
2009
Primary completion
2012
Study completion
2012
First posted
Jun 29, 2009
Registry last updated
Apr 13, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.